Atossa Genetics provides a revolutionary, patented, FDA-approved test for breast cancer that detects changes up to eight years before mammography. The Mammary Aspirate Specimen Cytology Test (MASCT) as it is called, is "The Pap Smear for Breast Cancer."
Specialties
Molecular diagnostics, Breast cancer
New hires at Atossa Genetics, Inc.
-
Business Development Specialist, Account Manager
Came from...
PerkinElmer, Scientific Application Specialist
